Autism spectrum disorders (ASD) are phenotypically and genetically diverse, which complicates our understanding and ability to develop treatments. If subsets of the genetically diverse forms of ASD were to converge on downstream cellular consequences, as has been suggested by Gene Ontology and co-expression analysis, then each subset might be amenable to a common treatment strategy. To find such convergent molecular mechanisms across diverse ASD-associated genes, we applied multiplexed transcriptional repression coupled to single-cell RNA sequencing in a model of human neuron differentiation and uncovered two functionally convergent modules of ASD genes: one that delays neuron differentiation and one that accelerates it. Five genes that delay neuron differentiation (ADNP, ARID1B, ASH1L, CHD2, and DYRK1A) mechanistically converge, as they all dysregulate genes involved in cell-cycle and progenitor cell proliferation. Live-cell imaging after individual ASD gene repression validated this functional module, confirming that these genes reduce neural progenitor cell proliferation and neurite growth. Finally, these functionally convergent ASD gene modules predicted shared clinical phenotypes among individuals with mutations in these genes.
Introduction
Autism spectrum disorder (ASD) afflicts 1 in 59 individuals in the United States and represents a substantial emotional and financial burden on our society 1 . Recent exome sequencing studies have identified over 100 genes that cause ASD when a single copy is mutated to a loss-of-function allele [2] [3] [4] [5] . While human genetic studies continue to associate an ever-growing number of genes with ASD, a caveat to this remarkable progress is that each casual gene is mutated in only a small number of affected individuals. This genetic heterogeneity provides a substantial challenge to the development of broadly useful therapeutics. If, at an extreme, each ASD-associated gene follows a separate mechanistic route to disease, then each will require the development of an independent therapeutic. On the other hand, if subsets of these genes converge in their mechanisms, then these points of convergence would be logical targets for more broadly applicable therapeutics that apply to the entire subset.
Despite the genetic heterogeneity in ASD, a large fraction of causative genes can be classified as either synaptic proteins or transcriptional regulators, suggesting convergent causal mechanisms at these levels 3, 6 . Further, while the developmental timing of ASD pathogenesis and the exact cell types implicated are not fully known, many ASD genes share high expression in developing fetal neural stem cells, fetal neurons, adult excitatory neurons, and medium spiny neurons 7, 8 . In addition, elegant integrative genomics approaches have clustered ASD genes into modules by their cell-type specific developmental expression trajectories and network connectivity 6, [8] [9] [10] . These studies implicitly predict that genes in the same module are functionally convergent; however, it is critical to test these predictions empirically. Testing these predictions requires establishing a high-throughput and disease-relevant model system to both perturb numerous ASD genes and systematically assess the functional consequences to identify convergent mechanisms.
While animal models and patient-derived induced pluripotent stem cell (iPSC) models can be used to study some of the relevant phenotypes of ASD, these systems are lowthroughput, require long generation times, and can vary greatly across laboratories, strains, or individuals 11, 12 . These caveats make it difficult to directly compare results across different models to assess mechanistic convergence. Fortunately, recent technological advancements coupling CRISPR/Cas9 transcriptional repression to singlecell RNA sequencing (scRNA-seq) enable high-throughput perturbation of multiple genes in a single batch with a parallel functional readout of the transcriptional consequences [13] [14] [15] [16] . Such an approach holds great promise for efficiently defining the functional consequences of loss-of-function mutations in ASD genes, as transcriptional repression could phenocopy haploinsufficiency. Further, since many ASD genes are transcriptional regulators, insights into the mechanisms by which they contribute to ASD can be gleaned by measuring the transcriptional consequences of their perturbation. As the pathology of many ASD genes likely arises during neural development, when proliferating progenitors are differentiating into post-mitotic neurons 17 , we have applied such a scalable approach to a human cellular model of neuron differentiation.
Here, we used catalytically inactive Cas9-based transcriptional repression (dCas9-KRAB) to knock down the expression of 14 ASD-related genes in a human cellular model of neurodevelopment and captured the resulting transcriptional consequences using scRNA-seq. For all candidate genes, we identified individual transcriptional signatures after repression. We found that many ASD genes altered the trajectory of neuronal differentiation when repressed. Furthermore, by clustering the disease genes by their shared transcriptional changes after perturbation, we identified two functional modules comprising sets of diverse autism genes that acted either by delaying or accelerating neuronal differentiation, respectively. Transcriptional convergence of these functional modules generated specific mechanistic hypotheses which we then tested and confirmed by combining individual knock-down experiments with live-cell imaging.
Integrating our data across modalities, we found a functional module of 5 ASD genes that act to delay neuron differentiation by disrupting cell-cycle and neural progenitor cell proliferation. We replicated these results in an orthogonal system using iPSCderived neural progenitor cells. Finally, we show that the functionally convergent ASD gene modules discovered by our experimental data predicted shared clinical phenotypes of individuals with mutations in these genes. These results demonstrate the promise of this approach to identify convergently disrupted cellular pathways across diverse causative genes and ultimately link them to clinical phenotypes.
Results

Establishing a human neurodevelopmental model for high-throughput evaluation of ASD gene perturbation
Human neuronal models are needed for studying neurodevelopmental disorders such as ASD 12 . While human iPSC-derived neurons are a powerful cellular model system, the genetic heterogeneity, variability of neuronal differentiation, and technical difficulties achieving efficient transcriptional modulation in these cells complicate transcriptomic and phenotypic analyses 18, 19 . Therefore, we aimed to establish a tractable, diploid human neuronal model amenable to differentiation and transcriptional perturbation to enable high-throughput evaluation of the consequences of ASD-gene repression. We selected the LUHMES neural progenitor cells as such a model for their capacity for rapid differentiation into post-mitotic neurons, potential relevance to neurological disorders, and suitability for high-content imaging [20] [21] [22] [23] [24] . To further validate the relevance of these cells, we performed RNA sequencing (RNA-seq) analysis of LUHMES cells at multiple time points after inducing differentiation. Hierarchical clustering analysis of differentially expressed genes across the differentiation time-course revealed that differentiation of LUHMES was rapid and reproducible (Pearson's r 2 between replicates > 0.99), with biological replicates clustering together and samples arranged temporally by their day of differentiation (Figure 1a, Supplementary Figure 1A ). Genes that turned off during differentiation were enriched for cell-cycle markers such as CCND2, genes involved in proliferation (MKI67 and TP53), as well as the canonical neural stem cell marker gene SOX2. Genes that increased expression during differentiation included known neuronal markers MAP2 and DCX, and were heavily enriched for critical neurodevelopmental pathways including axon development and neuron migration (Fig   1b Left) . Importantly, genes expressed during differentiation were strongly enriched for genes implicated in neurological disorders, including ASD (Fig 1b Right) . Cell typespecific expression analysis (CSEA) of differentiated LUHMES revealed that these neurons have transcriptional profiles that are highly similar to a number of neuronal subtypes relevant to neurological disorders (Supp Figure 1B) 7 . To assess the extent to which in vitro differentiation of LUHMES cells captures aspects of human brain development, we performed a transition-mapping approach comparing differentially expressed genes during LUHMES differentiation to the BrainSpan Atlas of Developing Human Brain (Methods) 25, 26 . We found that in vitro differentiation gene expression changes closely match transcriptional differences that occur in the early developing human fetal neocortex (Pearson's r = 0.69, Fig 1c) . This strong overlap suggests that LUHMES differentiation faithfully recapitulates many of the transcriptional pathways that are utilized during this critical neurodevelopmental window that has been implicated in the onset of neurodevelopmental and psychiatric disorders 8 .
To establish that this model is specifically appropriate for the study of ASD genes, we analyzed the 25 highest-confidence autism-causing genes in the SFARI database (category 1), a manually curated database of ASD-associated genes 27 . We found that 22/25 (88%) were highly expressed in these cells across differentiation time points. We selected 11 of these genes, plus 2 additional syndromic ASD genes (CTNND2 and MECP2) 28, 29 , and HDAC5 for perturbation experiments ( Table 1 , Fig 1d) . Selected genes were enriched for roles in transcriptional regulation (10/14) , and are all highly likely to act through haploinsufficiency 30, 31 . Although many of these genes are putative regulators of gene expression, integrative bioinformatics approaches have assigned the majority of genes into either no module (NA) or generic modules (ME2) ( We next sought to determine whether the expression of these ASD genes could be efficiently knocked down in LUHMES cells. Three guide RNAs (gRNAs) per candidate gene were cloned into a CRISPR-repression optimized vector that also allows recovery of the gRNA from scRNA-seq [33] [34] [35] . We validated the efficacy of repression for 2 gRNAs targeting each of 6 candidate genes using quantitative real-time PCR (qPCR) in LUHMES neural progenitor cells constitutively expressing dCas9-KRAB. All tested gRNAs induced significant downregulation of their target gene, with 11/12 eliciting a knockdown greater than 50% (Fig 1e) , a level that should phenocopy the autosomal-dominant lossof-function modes of our candidate genes. Altogether, these data support LUHMES as a relevant and facile cellular model to evaluate the downstream consequences of transcriptional perturbation of ASD genes. 
Pooled repression of ASD genes and scRNA-seq
Given the high success rate of gene knockdown in dCas9-KRAB LUHMES by individual gRNAs, we proceeded to produce pooled lentiviruses targeting all 14 candidate genes (3 gRNAs per gene), along with 5 non-targeting control gRNA sequences, for a total of 47 gRNAs. We infected dCas9-KRAB expressing LUHMES neuronal progenitors at a low multiplicity of infection such that most cells received 0 or 1 gRNAs according to a Poisson distribution. Following selection for gRNA-containing cells by puromycin for 4 days, neural progenitor cells were differentiated according to published protocols 20 (Methods). To ensure efficient CRISPR repression, we differentiated LUHMES for 7 days, a timepoint when RNA-seq indicated differentiation is largely complete in a population of cells. We then profiled the transcriptomes of more than 14,000 cells using droplet-based scRNA-seq across two replicate experiments 36 (Figure 2a ,b).
We were able to detect gRNA expression for the vast majority (~80%) of cells and restricted our analysis to the 8777 cells with only a single gRNA to ensure only one perturbation per cell (Fig 2b) . To demonstrate the efficacy of ASD-gene repression in the pooled experiment, we grouped single cells by their detected gRNAs and visualized expression of all targeted genes across these groups (Fig 2c) 37, 38 . This analysis revealed efficient repression for 13/14 genes in our library, with the expression of RELN too sparse in single-cell data to evaluate efficiency of repression. We used the MIMOSCA pipeline to further evaluate the knock-down efficiency of gRNAs on their target genes, which confirmed strong on-target repression 16 ( Supplementary Figure 2A ). Almost all gRNAs elicited significant repression of their target genes (Sup Fig 2B- demonstrates the efficient recovery of gRNAs from single-cell RNA-seq data. c) DotPlot representation of the expression of ASD candidate genes (columns) across cells grouped by targeted gene (rows). Expression values are Z-normalized within a column across cells grouped by targeted gene. All circles represent reduced gene expression, with darker values indicating lower expression. The dark diagonal reflects efficient repression in cells with a guide targeting a given gene. RELN was excluded from this plot since it was not appreciably detected in scRNA-seq data. d) MIMOSCA Beta estimates (log2 fold change) for individual gRNA knock-down efficiencies are highly reproducible across replicate experiments.
ASD-gene repression alters neurodevelopmental trajectory
Having demonstrated the efficient repression of targeted ASD genes in the pooled experiment, we next sought to assess the unique and shared downstream consequences Significant enrichments and depletions are marked with asterisks (chi-squared test, p < 0.01). e) Significantly decreased or increased average pseudotime scores relative to cells with non-targeting gRNAs (t-test, p < 0.01), indicate delayed or accelerated neuronal maturation. Boxed in purple is a module of ASD genes that delay neuronal differentiation by this metric. Boxed in red is a module of CHD8 and PTEN that promote neuronal maturation.
Recurrently dysregulated genes highlight convergent mechanisms of ASD genes
Notably, within each functional module of ASD genes defined by pseudotime analysis, specific state enrichment or depletion were not perfectly shared among module members (Fig 3d) . This raises the possibility that although the genes in a functional module may all act similarly to promote (or delay) neuron differentiation, they may do so through different molecular mechanisms. We therefore sought to further dissect the transcriptional networks affected by gene perturbation to learn whether they converge across the ASD genes within each module using differential gene expression analysis.
Our system is especially amenable to this type of analysis because all 14 genes are repressed in parallel in a completely isogenic model, overcoming many of the primary sources of variation in other models. Due to the low number of cells available for analysis of SETD5 and POGZ, we excluded these cells from differential expression analyses. For the remaining genes, we found dozens to hundreds of differentially expressed genes for each knock-down (Supplementary Table 1 ).
To identify transcriptionally convergent modules of diverse ASD-causing genes, we grouped cells by targeted gene and clustered them by the expression of genes that were found to be differentially expressed across three or more ASD-gene knockdowns.
Hierarchical clustering reflected modules of ASD genes that alter genes involved in neuronal differentiation, largely recapitulating the results of pseudotime analysis, and nominated ADNP as another member of the 'Delayed Differentiation' module (Supplementary Figure 5A ). Further supporting these results, Gene Ontology analysis of the set of dysregulated genes showed an enrichment of neuronal differentiation processes in the perturbed transcriptomes (Sup Fig 5B) . From this analysis, it appears that ANDP, ASH1L, CHD2, and DYRK1A repression acts through a shared transcriptional pathway to delay neuronal differentiation. However, pseudotime analysis revealed heterogeneity in neuronal differentiation progression so the shared changes could also be secondary to distinct transcriptional changes that occurred early in neuronal differentiation. To address this possibility, we leveraged the power of single-cell data to explicitly account for differences in neuronal maturity by stratifying samples based on pseudotime (Sup Fig 5C, Methods) . To retain enough cells per group for differential gene expression analysis, we dichotomized pseudotime status as either 'early' or 'late' and then recomputed differentially expressed genes for each ASD-gene knockdown within each group (Supplementary Tables 2 and 3 ).
Clustering pseudotime-stratified samples based on recurrently dysregulated genes (i.e. genes that were differentially expressed in three or more ASD-gene knockdown samples) revealed shared and distinct patterns of transcriptional dysregulation ( Figure   4a ). Clustering separated samples by early and late pseudotime status, and then by stage-specific transcriptional modules of ASD genes. Because the 'Delayed Differentiation' module genes clustered tightly at the early stage, we can infer that the decreased neuronal maturation detected by pseudotime analysis is a consequence of early-stage transcriptional dysregulation. To further resolve the molecular convergence of this module at the early stage, we extracted the overlapping differentially expressed genes across the five members of the module. As expected by the clustering results, the sets of transcriptional targets of all module members shared significant overlap (all pairwise hypergeometric p-values < 10 -22 , Fig 4b) . Differential gene expression analysis also indicated potential epistasis between some module members, with CHD2 downregulated by ADNP or ARID1B repression, and ASH1L downregulated by ARID1B repression. Despite these cells being post-mitotic, Gene Ontology enrichment of the recurrently dysregulated genes in the early stage samples highlighted specific processes disrupted, namely the G2/M transition of cell cycle and negative regulation of cell development (Fig 4c) . The disrupted genes themselves are not core cell-cycle regulators so this signature may rather reflect cell-cycle disruptions that occurred earlier in the differentiation protocol (Supplementary Table 4 ). Together these results suggest that CHD2, ASH1L, ARID1B, DYRK1A, and ADNP modulate a shared gene regulatory pathway active in early neurodevelopment, and that their haploinsufficiency causes cell-cycle disruption and impedes neuronal differentiation.
Notably, ADNP, CHD2, and ASH1L were also tightly clustered in late stage cells. This implies that not only do they influence a shared transcriptional network early in neurodevelopment, but they continue to share downstream molecular targets in maturing neurons. In contrast, hierarchical clustering does not support a convergence of PTEN and CHD8 at either the early or late stages. We found that dysregulated genes driving the clustering of late stage samples were enriched for processes specific to neuron maturation such as synapse organization, neuron projection, and regulation of axon diameter (Fig 4d) . The specificity of these terms highlights the added molecular resolution we achieved by accounting for differences in pseudotime in our analysis. To generate specific predictions regarding the effects of ASD-gene repression on neuronal projections (axons and dendrites), we clustered samples by the expression of these genes. We found that the tight clustering of ADNP, CHD2, and ASH1L was driven by the decreased expression of neuron maturation markers such as MAPT, NEFL, and MAP1B with concomitant up-regulation of annotated negative regulators of neuron projection and differentiation (Fig 4e) . These genes were driven in the opposite direction by PTEN.
From these results, we predict that knockdown of ADNP, CHD2, and ASH1L would decrease neuronal projections, whereas knockdown of PTEN would enhance this process. 
Live-cell imaging reveals abnormalities in proliferation and neurite extension and confirms transcriptome-based predictions
Our single-cell transcriptional analyses allowed us to make several explicit predictions about the consequences of ASD-gene repression on cellular phenotypes. Specifically, we predicted that if any of the genes in the 'Delayed Differentiation' module comprising ADNP, ARID1B, ASH1L, CHD2, and DYRK1A are repressed, then we would observe a reduction in proliferation. In contrast, we expected PTEN repression to promote proliferation. For neurite extension, we predicted that repression of at least ADNP, CHD2, and ASH1L will decrease outgrowth, whereas repression of PTEN would enhance extension. To test these predictions, we implemented live-cell imaging to measure cellular proliferation and neurite extension after individual knock-down of ASD genes ( Figure 5a ). We produced lentivirus expressing individual gRNAs that target candidate ASD genes and used them individually to infect dCas9-KRAB neuronal progenitor cells in an arrayed format. We imaged cells under both proliferative or differentiative conditions every 4 hours for 3 or 5 days, respectively, using the IncuCyte live-cell imaging system. Representative images for proliferation and neurite extension are shown (Fig 5b-c, Supplementary Figure 6 ). Remarkably, in these live-cell imaging experiments, we observed decreased proliferation after repression of each member of the 'Delayed Differentiation' module of ASD genes (Fig 5d) . In contrast, PTEN repression caused a major increase in proliferation, consistent with our prediction and its known function of inhibiting neural stem cell proliferation 43 .
For the neurite extension assay, most of our predictions were also confirmed (Fig 5e) , as repression of many genes in the 'Delayed Differentiation' module (ASH1L, ADNP, ARID1B, and DYRK1A) caused modest to severe reductions in neurite outgrowth.
Conversely, PTEN repression increased neurite extension in this assay, consistent with its role in enhancing the length of regenerating axons in vivo 44 . Together, proliferation and neurite extension assays confirmed the consequences of ASD-gene repression predicted by scRNA-seq analyses, offering further support for a module of ASD genes that act at an early-stage to delay neuron differentiation and decreasing proliferation.
CRISPR repression in iPSC neural progenitor cells confirms ASD gene modules and transcriptional convergence at cell-cycle dysregulation
To validate the early transcriptional convergence and effects on cellular proliferation of putative ASD gene modules in an orthogonal cellular model system, we performed CRISPR repression of individual genes in human iPSC-derived neural progenitor cells.
First, we confirmed that dCas9-KRAB repression was efficient in these cells for a subset of genes using qPCR (Figure 6a ). Next, we performed RNA-seq after knockdown of seven individual ASD genes and a non-targeting control (Methods). RNA-seq confirmed efficient knockdown for at least 5/7 target genes (Supplementary Figure 7A ). Clustering transcriptomes using principal component analysis closely reproduced the modules discovered in LUHMES, namely the clustering of four members of the 'Delayed Differentiation' module (ADNP, ARID1B, ASH1L, and DYRK1A) and the clustering of 'Accelerated Differentiation' module genes CHD8 and PTEN (Fig 6b) . These clusters were also observed by unsupervised hierarchical clustering of transcriptomes using highly variable genes (Supplementary Figure 7B) . As in LUHMES, the 'Delayed Differentiation' genes strongly converged at the level of transcriptional dysregulation (Fig 6c) , affecting genes enriched for roles in chromatin remodeling, Wnt signaling and cell-cycle regulation (Fig 6d) . Likewise, the 'Accelerated Differentiation' genes had strongly overlapping transcriptional consequences on both down-and up-regulated genes (Sup Fig 7C) leading to misregulation of cell-cycle genes and increased cell division pathways (Sup Fig 7D) . A proliferation assay in these cells after individual gene repression functionally confirmed that ASH1L and CHD2 decreased proliferation and CHD8 repression enhanced it (Fig 6e) . These results broadly confirm both the membership and functional interpretation of ASD-genes modules in a second human neural progenitor system. 
Functionally convergent ASD gene modules predict shared clinical phenotypes
We next sought to determine if the functional convergence of ASD genes observed in our cellular model could predict the convergence of clinical phenotypes for these genes.
To do so, we first created a comprehensive model of the functional convergence of ASD genes in our system by integrating the results of our pseudotime analysis, transcriptional clustering, and functional profiling by hierarchical clustering (Figure 7a ). This analysis again clearly separated the 'Delayed Differentiation' module genes from those in the 'Accelerated Differentiation' module. Next, we collated clinical phenotypes from individuals with dominant loss-of-function mutations in these genes and performed hierarchical clustering on these data 45 . Strikingly, clustering by clinical phenotypes fully recapitulated our proposed convergent modules and supports mechanistic links of convergent pathways to shared clinical outcomes (Fig 7b) . For example, individuals with mutations in the 'Delayed Differentiation' module genes were highly likely to have intellectual disability, consistent with increased severity owing to early neurodevelopmental dysregulation. This cohort has a higher incidence of microcephaly, consistent with the proliferation defects we observed. Likewise, individuals with PTEN and CHD8 mutations have a comparatively reduced prevalence of intellectual disability but a high prevalence of macrocephaly, consistent with the observed functional convergence of these genes on promoting neuronal differentiation, proliferation, and neurite outgrowth. Integrating pseudotime analysis, transcriptional clustering, and cellular phenotyping of individual ASD genes uncovered two consistent modules of genes with opposing functionality in altering the course of neuron differentiation. Such heterochronicity of neurodevelopmental gene expression networks and consequent dysregulation of neuron differentiation is a plausible mechanism underlying ASD pathology, and has been observed in cellular models of ASD 17, 46 . We identified a 'Delayed Differentiation' module comprised of 5 ASD-genes and predicted that the knockdown of these genes would decrease neural progenitor cell proliferation. We further predicted, for a subset of this 'Delayed Differentiation' module, that individual gene knockdown would decrease neuron projection. Finally, we also predicted that PTEN repression would increase both proliferation and neuron projection. We confirmed these predictions by performing live-cell imaging of cell proliferation and neurite extension after gene knockdown, providing experimental functional validation for these ASD genes. Convergence of ASD genes at the regulation of cell-cycle genes was supported in an orthogonal model using human iPSC-derived NPCs.
We demonstrated that LUHMES cells enable the rapid and robust generation of post-mitotic human neurons with transcriptional profiles that correspond closely to early human cortical development, a critical period of neurodevelopment that has been implicated in the etiology of ASD and other neurodevelopmental disorders. Validation of our results in human iPSC-derived NPCs further supports the utility of LUHMES for discovering early neurodevelopmental mechanisms of ASD-associated genes.
Alternative human neurodevelopmental models, such as iPSC-derived neurons and organoids, may be better suited for investigating genes and pathways involved in cellfate specification, neuronal migration, and neuronal activity but are significantly more heterogeneous and are more experimentally challenging.
Compared to traditional single ASD-gene knock-out or repression experiments in mice or human cells (e.g. refs. [47] [48] [49] [50] [51] ), our approach increases the number of genes that can be assayed in parallel while also overcoming many of the primary sources of variation in such models. This enables direct comparison of results across genes to discover convergent mechanisms. Current single-cell technology enables pathway-level inferences of transcriptional dysregulation and prioritization of candidate genes for further functional validation in a rapid and cost-effective manner for tens of disease implicated genes. Noise and sparsity in single cell RNA-seq data limit its power to detect differentially expressed genes, but improvements in the sensitivity and throughput of scRNA-seq will enhance its utility in future experiments.
A major strength of our approach is its extensibility across any gene set, cell type of interest, and cellular phenotype measurable by imaging, which should facilitate higher throughput disease modeling efforts. Although we only measured proliferation and neurite extension with live-cell imaging, the integration of these data with pooled transcriptomes revealed gene modules that were also convergent at the level of clinical phenotypes in individuals with mutations in these genes 45 , illustrating the potential of this approach in linking molecular pathways to clinical phenotypes. Furthermore, while not implemented in this study, this approach is amenable to screening of chemical libraries to discover effective pharmaceutical interventions for any observed defects, and to determine whether convergent genetic modules will respond to common treatments. Such high-content imaging and screening in future experiments will enable detailed characterization of perturbation-induced neuronal phenotypes and the discovery of convergent molecular endophenotypes of disease pathogenesis. RNA-seq libraries were prepared by BRB-seq 54 . For proliferation assays, TRE dCas9-KRAB XCL4 cells were infected in quadruplicate with gRNAs targeting 7 ASD-genes and 1 nontargeting gRNA. After puromycin selection and doxycycline induction, cells were grown for 8 days and total cells were counted using a hemocytometer.
Materials and Methods
gRNA Cloning
For each target gene, we selected three gRNAs optimized for repression from the Dolcetto library 34 . These gRNAs direct dead Cas9 (dCas9) to a window 25-75 nucleotides downstream of the gene's transcription start site. gRNAs were screened for sequence features predicting high activity and no off-target effects. gRNAs were cloned into a CRISPR-repression optimized vector to enable pooled lentiviral preparation without guide-barcode swapping [33] [34] [35] . Lentiviral gRNA expression vectors were created by annealing two complementary oligonucleotides encoding gRNAs at 100 µM (IDT DNA) with sticky-ends and ligating annealed products into BsmB1 digested CROP-seq-opti vector using Golden Gate assembly. CROP-seq-opti was a gift from Jay Shendure (Addgene #106280) 33 . Each Golden Gate assembly reaction contained 6.5 µL water, 1 µL 1:10 diluted annealed oligos, 1 µl T4 ligase, 1 µl T4 ligase buffer, and 0.5 µL BsmB1.
Reactions were incubated at 16 ˚C for 10 minutes (ligation) and 55 ˚C for 10 minutes Figure 8A ). We hypothesized that their depletion was the result of fitness defects caused by the repression of these genes 56, 57 . To test this, we infected neural progenitor cells individually with three of the depleted gRNAs and monitored cell proliferation using live-imaging. Compared to a non-targeting gRNA, all of the depleted gRNAs caused a significant reduction in cellular proliferation, explaining why few cells with these gRNAs were detected in our pooled experiment (Supp Fig 8B) .
Lentiviral transduction of gRNAs
Bioinformatic Analyses
Sequencing data corresponding to single-cell transcriptomes were processed using the 10X software package Cell Ranger (v 2.1.0). We used this software to map reads to hg38 using STAR (v2.5.1b). The output filtered gene expression matrices were imported into R (v 3.5.1) for further analysis. Most analyses were performed using the Seurat (v3.0) and
Monocle (v2.10.0) packages. Individual cells were sequenced to an average depth of 50,208 ± 7,310 mapped reads per cell (2,145 ± 448 genes detected, 6,625 ± 1766 unique molecular identifiers (UMIs)). Quality control was performed in Seurat by computing the number of transcripts per cell and the percentage of mitochondrial gene expression. Cells with more than 500 but fewer than 7500 detected genes, and less than 8% mitochondrial gene expression were retained. gRNAs were detected by next-generation sequencing of the custom gRNA-enrichment PCR. Look-up tables of gRNA and cell barcodes were generated using custom Python scripts with a detection threshold of 20
UMIs per gRNA-cell barcode combination. Cell barcodes from filtered high-quality cells were matched against this table and only cells with a single gRNA were retained for analysis. Differences in total UMIs, experimental batch, and mitochondrial percentage were accounted for during data normalization. Normalized filtered data were used for the remaining analyses. For each perturbation, we grouped all cells with any of the three gRNAs targeting the same gene, as we have demonstrated that all three gRNAs typically have strong on-target activity (Sup Fig 2D) .
Clustering Analysis
Dimensionality reduction was performed by running principal component analysis (PCA) and clustering cells by the first 6 PCAs using UMAP 58 . To assess global variation in transcriptional states, we visualized all single cell transcriptomes on the UMAP. This revealed that over 99% of all cells formed a single cluster of post-mitotic neurons as defined by the absence of proliferative marker expression (Sup Fig 3A-B) . This is consistent with our experimental design capturing a single timepoint (day 7) in a rapid isogenic model of neuronal differentiation. Within the major cluster, however, the expression of markers of neuronal differentiation showed variable patterns across the UMAP (Sup Fig 3C-F) . Moreover, the most variably expressed genes in single-cell transcriptomes were enriched for functional roles in neurogenesis and axon projection, suggesting heterogeneity of neuronal differentiation at the single-cell level.
Pseudotime Analysis
We projected cells in pseudotime in Monocle by ordering cells by highly variable genes.
Dimensionality reduction was performed using the "DDRTree" method. Trajectories based on different sets of highly variable genes were qualitatively similar, showing a single trajectory with only minor branching. To ensure high correlation between pseudotime and neuron differentiation status, we computed the stage-specific genes in the bulk RNA-seq dataset for each day of differentiation and used these genes for pseudotime ordering. We then transferred pseudotime state labels into Seurat to discover marker genes for each pseudotime state. Transferring pseudotime labels onto the UMAP plot showed distinct banding patterns representing subtle transcriptional state differences within the main cluster (Supplementary Figure 9A ). Re-clustering the earliest and latest pseudotime labeled cells revealed two completely distinct cell states expressing either differentiation (NEUROD1) or maturation (STMN2) markers 59, 60 (Supp Fig 9C-E) . This confirms that pseudotime is more sensitive to detect biologically relevant transcriptional patterns than UMAP clustering in our dataset. We tested for altered pseudotime state membership proportions for each gRNA using chi-squared test. We computed the distribution of pseudotime state scores for each gRNA, and compared their averages using t-test.
Transition Mapping of LUHMES Differentiation
Transition mapping allows the comparison of in vitro neuron differentiation to in vivo development by computing the overlap of differentially expressed genes at selected time points across datasets 25 . We compared the in vitro LUHMES differentiation timepoints day 0 to day 8 to transcriptional changes across brain regions and developmental timepoints in the BrainSpan Atlas of the Developing Human Brain.
LUHMES differentiation had the strongest overlap with transcriptional changes occurring in the cortex of post-conception week 8-10 embryos and week 10-13 embryos.
Differential Gene Expression Analysis
Differential gene expression testing was performed using the FindMarkerGenes function in Seurat using the Wilcoxon Rank Sum test and a relaxed log2FC threshold of 0.1 to increase the number of differentially expressed genes. This cutoff was calibrated against a 'gold standard' dataset comparing single-cell and bulk RNA-seq data to identify differentially expressed genes 61 . To find marker genes of pseudotime state clusters, only positive markers were returned.
Pseudotime state by was binarized with states 1-3 labeled as 'early' and states 4-6 as 'late'. We next created another label combining the targeted gene with binary pseudotime state (e.g. CHD8_early). Averaged profiles were re-computed for each group based on these new labels and differentially expressed genes were also recalculated. Principal component analysis and hierarchical clustering were performed on these samples. As expected, unsupervised clustering of the stratified profiles by principal component analysis perfectly discriminated between 'early' and 'late' samples (Sup Fig 5C) . This analysis showed that the first principal component corresponds to pseudotime status and explains almost 20% of the total variance in the dataset. Gene Ontology and pathway enrichment analyses were performed using WebGestalt 62 .
Live-cell Imaging
Cells were imaged using an IncuCyte S3 live imaging system (Essen BioScience) For each experiment, dCas9-KRAB LUHMES were infected in duplicate with individual gRNAs and were plated in duplicate in wells of a 24 well plate in either self-renewing or
